Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2001

View Archived Issues

Aurora and R.W. Johnson expand ion channel technology agreement

Warning issued regarding Zerit/Videx combination therapy use in pregnant women

Cambridge NeuroScience receives SBIR grant related to peripheral nerve dysfunction

European commercialization license for Cidecin granted to Gilead

Cell Therapeutics outlines 2001 goals

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Neurogen and Pfizer extend collaboration related to GABA system

Coronary artery stenosis prevented by TAS-301 in pigs with balloon overstretch injury

BioChem Pharma completes acquisition of CliniChem

Efficacy and safety of JAK3 inhibitors in allergic asthma validated using WHI-P97

Oxford BioMedica develops Lentivector transport technology with neurological applications

FDA issues nonapprovable letter for Atragen; company plans to continue development

Four-year PROactive study examines effects of Actos on cardiovascular risk

Wide series of CDK/cyclin inhibitors developed at Pharmacia

Symbicort combination asthma product approved in E.U.

Short-acting benzodiazepines and their use claimed by Glaxo (GlaxoSmithKline)

Inhibitors of essential bacterial enzymes disclosed in recent patent

Benzimidazole-based antibacterial agents in the GlaxoSmithKline pipeline

New substance P antagonists particularly useful for emesis

Several related classes of anticoagulants, their preparation, activity and use reported

Matrix completes NDA filing for IntraDose injectable gel

Important Japanese approvals received and pending for AstraZeneca

Zometa granted positive opinion from CPMP

IND submitted for salmon calcitonin as oral osteoporosis treatment

Phytopharm reports promising clinical trial results for P-54 in colorectal cancer

Potent new nonpeptide ORL1 receptor agonist discovered at Novo Nordisk

Novogen begins second phase I trial of anticancer agent in Australia

Ferring designs very-long-acting GnRH antagonist with other advantageous properties

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...